» Articles » PMID: 19251154

Bacterial Keratitis Early After Corneal Crosslinking with Riboflavin and Ultraviolet-A

Overview
Specialty Ophthalmology
Date 2009 Mar 3
PMID 19251154
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

We report a case of bacterial keratitis 3 days after corneal crosslinking for keratoconus. The patient complained of increasing pain and redness combined with blurred vision in the treated eye starting on the first postoperative day. Clinical examination showed multiple stromal infiltrations and moderate anterior chamber inflammation. Corneal scraping revealed an Escherichia coli infection, which was successfully treated with fortified tobramycin and cephazolin eyedrops for several weeks. This is the first report of a case of rare postoperative complication resulted in an avascularized corneal scar and permanent reduction of the visual acuity.

Citing Articles

Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study.

Hafezi F, Torres-Netto E, Kollros L, Lu N, Hafezi N, Mazzotta C Eye Vis (Lond). 2023; 10(1):36.

PMID: 37653457 PMC: 10472555. DOI: 10.1186/s40662-023-00354-1.


Severe Complications after Corneal Collagen Cross-Linking (CXL).

Blaser F, Zweifel S, Wiest M, Bajka A, Said S, Barthelmes D Klin Monbl Augenheilkd. 2023; 240(4):369-378.

PMID: 37164391 PMC: 10129411. DOI: 10.1055/a-2040-4290.


Best Fit Sphere Back and Adjusted Maximum Elevation of Corneal Back Surface as Novel Predictors of Keratoconus Progression.

Ribeiro M, Barbosa C, Correia P, Torrao L, Cardoso P, Moreira R Clin Ophthalmol. 2022; 16:4239-4248.

PMID: 36573232 PMC: 9789719. DOI: 10.2147/OPTH.S388614.


Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study.

Ferdi A, Kandel H, Nguyen V, Tan J, Arnalich-Montiel F, Abbondanza M Clin Exp Ophthalmol. 2022; 51(1):9-18.

PMID: 36240047 PMC: 10091974. DOI: 10.1111/ceo.14177.


The Safety Profile of FDA-Approved Epithelium-Off Corneal Cross-Linking in a US Community-Based Healthcare System.

Ang M, Darbinian J, Hoskins E, Holsclaw D, Sudesh S, Chandra N Clin Ophthalmol. 2022; 16:1117-1125.

PMID: 35431539 PMC: 9012302. DOI: 10.2147/OPTH.S359224.